Both in Lab Analytical Instruments
Rapid Micro Biosystems vs Harvard Bioscience
Over the past year RPID returned −74.8% and HBIO returned +51.0%; their daily moves had a correlation of -0.19.
RPID −74.8% HBIO +51.0%Growth of $1, one year, split-adjusted
| Metric | RPID | HBIO |
|---|---|---|
| Price | $0.6920 | $8.67 |
| Market cap | $34.7M | $39.5M |
| Today | −1.54% | +0.81% |
| 1 month | −29.1% | +2.0% |
| 6 months | −72.1% | +30.8% |
| Year to date | −76.1% | +29.6% |
| 1 year | −76.9% | +67.8% |
| Revenue growth (YoY) | +10.9% | +11.1% |
| Gross margin | 15.0% | 55.6% |
| Net margin | −160.5% | −12.8% |
| P/E (TTM) | — | — |
| Price / sales | 1.0× | 0.4× |
| Net cash | $627.0K | -$30.2M |
| Dividend yield | — | — |
| Volatility (60d) | 57.2% | 36.3% |
| Short % of float | 3.9% | 1.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).